India began vaccinating its population against the coronavirus with Sputnik V

This Friday, the vaccination with the Russian immunizer began Sputnik V on India. This was announced in a statement by the Russian sovereign fund (RDIF), which financed part of the development of the vaccine against him coronavirus and negotiates production agreements abroad.

SIGHT: India joins political battle for vaccines amid coronavirus “apocalypse”

Sputnik V became the first foreign vaccine used in India”Said the RDIF, stressing that the first injections were given in Hyderabad (center), after the first batch of vaccines entered the Asian country on May 1, 2021. A second shipment will arrive at Indiaat the end of the week”.

  • Brazil reiterates interest in the Russian Sputnik V vaccine and hopes for a prompt solution to the impasse
  • What happens if the Pfizer and AstraZeneca vaccines are mixed?
  • Venezuela receives 50,000 more doses of the Russian vaccine Sputnik V against the coronavirus

India it is suffering from a devastating epidemic explosion and several states across the country are suffering from vaccine shortages.

SIGHT: India: dozens of bodies of possible coronavirus victims found on the banks of the Ganges river

The Russian fund recalls that the immunizing Sputnik V was approved for emergency use in India 12th April.

A COVID-19 coronavirus patient receives oxygen supply at a Sikh shrine on the outskirts of New Delhi, India. (EFE / EPA / IDREES MOHAMMED).

India it will also be “the main production center of Sputnik V”Indicated the RDIF, which recalled having signed production agreements with large Indian pharmaceutical groups to produce more than 850 million doses per year in the future.

SIGHT: India Detects Rise in Deadly Fungus Infections in Coronavirus Cases

According to the RDIF, the Russian vaccine is already licensed in 65 countries, and covers about 3.2 billion people.

The Sputnik V vaccine was initially greeted with skepticism abroad but its reliability was confirmed in February by the scientific journal. The Lancet.

Your request for approval is currently being examined by the European Medicines Agency (EMA).

RECOMMENDED VIDEO

IT MAY INTEREST YOU

  • Coronavirus: Bill Gates’ forecast on when and how it will return to normal
  • “In the 70s Venezuela was modernity”: 3 Colombians who emigrated decades ago and do not want to return (despite the crisis)
  • How aggressive is the Indian variant of coronavirus and why we know so little about it
  • North Miami Beach will no longer vaccinate tourists for free against the coronavirus, as offered by its mayor
  • The situation in India due to the coronavirus is “more than heartbreaking”, warns the WHO
  • Israel beats the coronavirus: detects only 38 cases in a day, the lowest number in a year

.

Disclaimer: If you need to update/edit/remove this news or article then please contact our support team Learn more

Leave a Reply